NCT07757412
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07757412
Title Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma. (ADAPTATION)
Acronym ADAPTATION
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Odense University Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries NOR | FIN | EST | DNK

Facility Status City State Zip Country Details
AUH Aarhus Denmark Details
OUH Odense Denmark Details
North Estonia Medical Centre Tallinn Estonia Details
Tartu University Hospital Tartu Estonia Details
Helsinki University Hospital Comprehensive Cancer Center Helsinki Finland Details
Oslo University Hospital, Oslo Myeloma Centre Oslo Norway Details
Stavanger University Hospital Stavanger Norway Details
St. Olavs Hospital Trondheim Norway Details
Vestfold Hospital Tønsberg Norway Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field